Platinum concentration in sentinel lymph nodes after preoperative intra-arterial cisplatin chemotherapy targeting oral cancer

Platinum concentration in sentinel lymph nodes after preoperative intra-arterial cisplatin chemotherapy targeting oral cancer - Platinum concentration in sentinel lymph nodes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017578

Enrollment

Registered

2015-05-15

Start date

2009-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

untreated oral cancer

Interventions

angiography intra-arterial infusion of cisplatin sentinel lymph node biopsy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Histologically proven squamous cell carcinoma 2. Planned surgery for primary tumor 3. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Distant metastasis 2. Planned reconstruction by free flap transfer after primary tumor resection

Design outcomes

Primary

Measure	Time frame
To compare platinum concentrations in sentinel lymph nodes and non-sentinel lymph nodes	—

Secondary

Measure	Time frame
1. Presence of metastasis to sentinel lymph nodes 2. histopathological effect to metastatic sentinel lymph nodes	—

Countries

Japan

Contacts

Public ContactAkihiro Homma

Hokkaido University Graduate School of Medicine Department of Otolaryngology-Head and Neck Surgery

ak-homma@med.hokudai.ac.jp011-706-5958

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026